NOT FOR DISTRIBUTION
Header cover image

Consulting & Investment Group

Market Cap

د.أ25.6m

Last Updated

2021/09/17 11:32 UTC

Data Sources

Company Financials

Executive Summary

The Consulting & Investment Co. Group. Ltd. More Details


Snowflake Analysis

Adequate balance sheet and overvalued.

Share Price & News

How has Consulting & Investment Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: Insufficient data to determine CICO's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine CICO's volatility change over the past year.


Market Performance


7 Day Return

-0.8%

CICO

-0.8%

JO Healthcare

-0.4%

JO Market


1 Year Return

-11.1%

CICO

4.9%

JO Healthcare

36.5%

JO Market

Return vs Industry: CICO underperformed the JO Healthcare industry which returned 4.9% over the past year.

Return vs Market: CICO underperformed the JO Market which returned 36.5% over the past year.


Shareholder returns

CICOIndustryMarket
7 Day-0.8%-0.8%-0.4%
30 Day-1.5%-6.1%3.2%
90 Dayn/a-16.2%-6.2%
1 Year-11.1%-11.1%6.0%4.9%40.7%36.5%
3 Year-21.4%-24.1%28.0%22.7%11.0%0.5%
5 Year126.5%100.8%29.3%19.7%17.5%-2.9%

Long-Term Price Volatility Vs. Market

How volatile is Consulting & Investment Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Consulting & Investment Group undervalued compared to its fair value and its price relative to the market?

1.27x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate CICO's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate CICO's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: CICO is unprofitable, so we can't compare its PE Ratio to the Asian Healthcare industry average.

PE vs Market: CICO is unprofitable, so we can't compare its PE Ratio to the JO market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CICO's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CICO is good value based on its PB Ratio (1.3x) compared to the XA Healthcare industry average (2.3x).


Future Growth

How is Consulting & Investment Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

19.8%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Consulting & Investment Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Consulting & Investment Group performed over the past 5 years?

3.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CICO is currently unprofitable.

Growing Profit Margin: CICO is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CICO is unprofitable, but has reduced losses over the past 5 years at a rate of 3.2% per year.

Accelerating Growth: Unable to compare CICO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CICO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (34.1%).


Return on Equity

High ROE: CICO has a negative Return on Equity (-1.55%), as it is currently unprofitable.


Financial Health

How is Consulting & Investment Group's financial position?


Financial Position Analysis

Short Term Liabilities: CICO's short term assets (JOD7.0M) exceed its short term liabilities (JOD6.8M).

Long Term Liabilities: CICO's short term assets (JOD7.0M) exceed its long term liabilities (JOD4.9M).


Debt to Equity History and Analysis

Debt Level: CICO's debt to equity ratio (0%) is considered satisfactory.

Reducing Debt: CICO's debt to equity ratio has reduced from 4.9% to 0% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if CICO has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if CICO has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Consulting & Investment Group current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CICO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CICO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CICO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CICO's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CICO's dividend in 3 years as they are not forecast to pay a notable one for the JO market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

13.7yrs

Average management tenure


CEO

Consulting & Investment Group has no CEO, or we have no data on them.


Leadership Team

Experienced Management: CICO's management team is seasoned and experienced (13.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

The Consulting & Investment Co. Group. Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: The Consulting & Investment Co. Group. Ltd.
  • Ticker: CICO
  • Exchange: ASE
  • Founded: 1995
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: د.أ25.600m
  • Shares outstanding: 20.00m
  • Website: https://www.istisharihospital.com

Location

  • The Consulting & Investment Co. Group. Ltd.
  • Wadi Saqra
  • PO Box 840431
  • Amman
  • 11184
  • Jordan

Listings


Biography

The Consulting & Investment Co. Group. Ltd. provides medical care services in Jordan.It also sells medicines. The company was founded in 1995 and is based in Amman, Jordan.


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/17 11:32
End of Day Share Price2021/09/16 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.